|
|
||||||||
Papers In Press, published online ahead of print December 3, 2005
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Children's Hospital of Philadelphia, Philadelphia, PA 19104
Corresponding Author: rothblat{at}email.chop.edu
Abstract: We developed an assay that quantitates bidirectional cholesterol flux between cells and lipoproteins. Incubating Fu5AH cells with increasing concentrations of human serum resulted in increased influx and efflux, however, influx was 2-3 fold greater at all serum concentrations. With apo B-depleted serum the ratio of influx to efflux (I/E) was close to 1, indicating cholesterol exchange. The apo B fraction of serum induced influx and little efflux, with I/E greater than 1. Using BLT-1 to block SR-BI-mediated flux with different acceptors we determined 50% to 70% of efflux was via SR-BI. With HDL, 90% of influx was via SR-BI, whereas with LDL or serum 20% of influx was SR-BI-mediated. Cholesterol-enriched hepatoma cells produced increased efflux without change in influx, resulting in reduced I/E. The assay was applied to cholesterol normal and enriched mouse peritoneal macrophages exposed to serum or LDL. The enrichment enhanced efflux without shifts in influx. With cholesterol-enriched macrophages HDL efflux was enhanced while influx was greatly reduced. With all lipoproteins cholesterol enrichment of MPM led to a reduced I/E. We conclude that this assay can simultaneously and accurately quantitate the cholesterol bidirectional flux and can be applied to a variety of cells exposed to isolated lipoproteins or serum.
Revised on December 2, 2005
Accepted on December 2, 2005
Measurement of cholesterol bidirectional flux between cells and lipoproteins
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
S. A. Fenske, A. Yesilaltay, R. Pal, K. Daniels, A. Rigotti, M. Krieger, and O. Kocher Overexpression of the PDZ1 Domain of PDZK1 Blocks the Activity of Hepatic Scavenger Receptor, Class B, Type I by Altering Its Abundance and Cellular Localization J. Biol. Chem., August 8, 2008; 283(32): 22097 - 22104. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. P. Adorni, F. Zimetti, J. T. Billheimer, N. Wang, D. J. Rader, M. C. Phillips, and G. H. Rothblat The roles of different pathways in the release of cholesterol from macrophages J. Lipid Res., November 1, 2007; 48(11): 2453 - 2462. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. J. F. Nieland, J. T. Shaw, F. A. Jaipuri, Z. Maliga, J. L. Duffner, A. N. Koehler, and M. Krieger Influence of HDL-cholesterol-elevating drugs on the in vitro activity of the HDL receptor SR-BI J. Lipid Res., August 1, 2007; 48(8): 1832 - 1845. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. A. Morehouse, E. D. Sugarman, P.-A. Bourassa, T. M. Sand, F. Zimetti, F. Gao, G. H. Rothblat, and A. J. Milici Inhibition of CETP activity by torcetrapib reduces susceptibility to diet-induced atherosclerosis in New Zealand White rabbits J. Lipid Res., June 1, 2007; 48(6): 1263 - 1272. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Parathath, Y. F. Darlington, M. de la Llera Moya, D. Drazul-Schrader, D. L. Williams, M. C. Phillips, G. H. Rothblat, and M. A. Connelly Effects of amino acid substitutions at glycine 420 on SR-BI cholesterol transport function J. Lipid Res., June 1, 2007; 48(6): 1386 - 1395. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Dreux, T. Pietschmann, C. Granier, C. Voisset, S. Ricard-Blum, P.-E. Mangeot, Z. Keck, S. Foung, N. Vu-Dac, J. Dubuisson, et al. High Density Lipoprotein Inhibits Hepatitis C Virus-neutralizing Antibodies by Stimulating Cell Entry via Activation of the Scavenger Receptor BI J. Biol. Chem., July 7, 2006; 281(27): 18285 - 18295. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
| All ASBMB Journals | Journal of Biological Chemistry |
| Molecular and Cellular Proteomics | ASBMB Today |